Covid-19 could mean Medtronic loses out to Abbott, its rival in the mitral valve space.
Sales of implants are set to fall sharply as non-urgent procedures are deferred.
20 key healthcare transactions, most struck before the Covid-19 pandemic hit, have yet to be formally completed.
The orthopaedics sector has seen several sizeable mergers over the past decade. Might it see more?
Stryker’s scale-building efforts have been notable over the past few years, and at $4.7bn this is its largest-ever deal.
The speediest device developer is Roche, but a look at companies’ strategies shows the perils of relying on bought-in tech.
Deal is the fifth largest robotics surgery purchase ever, and the second big move from Stryker.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.
Acelity falls to 3M, but the conglomerate has taken on a great deal of debt and could see its credit rating fall.